This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2015 Sep 10;373(11):1079-82.

doi: 10.1056/NEJMc1504261.

Squamous Change in Basal-Cell Carcinoma with Drug Resistance

Katherine J Ransohoff¹, Jean Y Tang, Kavita Y Sarin

Affiliations

PMID: 26352826
DOI: 10.1056/NEJMc1504261

Case Reports

Squamous Change in Basal-Cell Carcinoma with Drug Resistance

Katherine J Ransohoff et al. N Engl J Med. 2015.

. 2015 Sep 10;373(11):1079-82.

doi: 10.1056/NEJMc1504261.

Authors

Katherine J Ransohoff¹, Jean Y Tang, Kavita Y Sarin

Affiliation

¹ Stanford University School of Medicine, Redwood City, CA tangy@stanford.edu.

PMID: 26352826
DOI: 10.1056/NEJMc1504261

No abstract available

PubMed Disclaimer

Similar articles

Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib.
Iarrobino A, Messina JL, Kudchadkar R, Sondak VK. Iarrobino A, et al. J Am Acad Dermatol. 2013 Jul;69(1):e33-4. doi: 10.1016/j.jaad.2013.01.023. J Am Acad Dermatol. 2013. PMID: 23768306 No abstract available.
Defining locally advanced Basal cell carcinoma.
Maly TJ, Sligh JE. Maly TJ, et al. J Drugs Dermatol. 2014 May;13(5):528-9. J Drugs Dermatol. 2014. PMID: 24809873 No abstract available.
Vismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation.
Ighilahriz M, Benfodda M, Sharpe H, Soufir N, Mourah S, Dumaz N, Battistella M, Savina A, Bouquet F, Nikolaev S, Basset-Seguin N. Ighilahriz M, et al. J Eur Acad Dermatol Venereol. 2019 Nov;33(11):e422-e424. doi: 10.1111/jdv.15741. Epub 2019 Jul 15. J Eur Acad Dermatol Venereol. 2019. PMID: 31187903 No abstract available.
Compassionate use of vismodegib and adjuvant radiotherapy in the treatment of multiple locally advanced and inoperable basal cell carcinomas and squamous cell carcinomas of the skin.
Gathings RM, Orscheln CS, Huang WW. Gathings RM, et al. J Am Acad Dermatol. 2014 Apr;70(4):e88-e89. doi: 10.1016/j.jaad.2013.11.032. J Am Acad Dermatol. 2014. PMID: 24629372 Review. No abstract available.
New Perspectives in the Pharmacological Treatment of Non-Melanoma Skin Cancer.
Savoia P, Cremona O, Fava P. Savoia P, et al. Curr Drug Targets. 2016;17(3):353-74. doi: 10.2174/1389450116666150806123717. Curr Drug Targets. 2016. PMID: 26245477 Review.

See all similar articles

Cited by

Clonal replacement of tumor-specific T cells following PD-1 blockade.
Yost KE, Satpathy AT, Wells DK, Qi Y, Wang C, Kageyama R, McNamara KL, Granja JM, Sarin KY, Brown RA, Gupta RK, Curtis C, Bucktrout SL, Davis MM, Chang ALS, Chang HY. Yost KE, et al. Nat Med. 2019 Aug;25(8):1251-1259. doi: 10.1038/s41591-019-0522-3. Epub 2019 Jul 29. Nat Med. 2019. PMID: 31359002 Free PMC article.
c-FOS drives reversible basal to squamous cell carcinoma transition.
Kuonen F, Li NY, Haensel D, Patel T, Gaddam S, Yerly L, Rieger K, Aasi S, Oro AE. Kuonen F, et al. Cell Rep. 2021 Oct 5;37(1):109774. doi: 10.1016/j.celrep.2021.109774. Cell Rep. 2021. PMID: 34610301 Free PMC article.
Metastatic same-site squamous cell carcinoma arising during vismodegib therapy for basal cell carcinoma.
Zhao R, Wang B, Lowe L, Dlugosz A, Bichakjian CK. Zhao R, et al. JAAD Case Rep. 2022 Aug 10;28:54-57. doi: 10.1016/j.jdcr.2022.07.032. eCollection 2022 Oct. JAAD Case Rep. 2022. PMID: 36097620 Free PMC article. No abstract available.
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies.
Farberg AS, Portela D, Sharma D, Kheterpal M. Farberg AS, et al. Am J Clin Dermatol. 2024 Sep;25(5):779-794. doi: 10.1007/s40257-024-00870-3. Epub 2024 Jun 19. Am J Clin Dermatol. 2024. PMID: 38896403 Free PMC article. Review.
Acquisition of Drug Resistance in Basal Cell Nevus Syndrome Tumors through Basal to Squamous Cell Carcinoma Transition.
Jussila AR, Haensel D, Gaddam S, Oro AE. Jussila AR, et al. J Invest Dermatol. 2024 Jun;144(6):1368-1377.e6. doi: 10.1016/j.jid.2023.10.040. Epub 2023 Dec 28. J Invest Dermatol. 2024. PMID: 38157930

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information